Celltrion
068270.KS
#829
Rank
โ‚น2.514 T
Marketcap
โ‚น11,179
Share price
0.38%
Change (1 day)
12.53%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: โ‚น2.514 Trillion

As of December 2025 Celltrion has a market cap of โ‚น2.514 Trillion. This makes Celltrion the world's 829th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น2.514 T11.06%
2024โ‚น2.263 T-18.78%
2023โ‚น2.787 T85.78%
2022โ‚น1.500 T-13.07%
2021โ‚น1.725 T-47.67%
2020โ‚น3.297 T132.25%
2019โ‚น1.419 T-18.24%
2018โ‚น1.736 T5.66%
2017โ‚น1.643 T122.48%
2016โ‚น738.73 B37.54%
2015โ‚น537.10 B134%
2014โ‚น229.53 B4.15%
2013โ‚น220.37 B-7.37%
2012โ‚น237.92 B23.17%
2011โ‚น193.16 B25.04%
2010โ‚น154.47 B152.45%
2009โ‚น61.19 B57.84%
2008โ‚น38.76 B5187.57%
2007โ‚น0.73 B